Study of Glasdegib with Intensive or Standard Chemotherapy in Patients with Untreated Acute Myeloid
Leukemia. A Randomized (1:1), Double-Blind, Multi-Center, Placebo Controlled Study Evaluating Intensive Chemotherapy With or Without Glasdegib (PF-04449913) or Azacitidine (AZA) With or Without Glasdegib in Patients With Previously Untreated Acute Myeloid Leukemia.